Literature DB >> 10456946

Observed differences in virulence-associated phenotypes between a human clinical isolate and a veterinary isolate of Mycobacterium avium.

K A Birkness1, W E Swords, P H Huang, E H White, C S Dezzutti, R B Lal, F D Quinn.   

Abstract

Mycobacterium avium, the most common opportunistic pathogen in patients with AIDS, is frequently isolated from a variety of environmental sources, but rarely can these environmental isolates be epidemiologically linked with isolates known to cause human disease. Using a number of in vitro tissue culture assays, we found significant pathogenic differences between a serotype 4 human clinical M. avium isolate and a serotype 2 veterinary isolate. Cell association of the patient strain with a human intestinal cell line was 1.7 times that of the veterinary strain. Growth of this clinical strain in human peripheral blood mononuclear cell-derived macrophages increased from 12-fold higher than that of the veterinary isolate after 2 days to 200-fold higher after 4 days. By the conclusion of each experiment, lysis of all examined host cell types and accumulation of cell debris were observed in infections with the human isolate, but monolayers remained relatively intact in the presence of the animal isolate. The two strains also differed in the ability to stimulate human immunodeficiency virus replication in coinfected host cells, with p24 antigen levels after 6 days threefold higher in the cells coinfected with the clinical strain than in those infected with the veterinary strain. If the genetic differences responsible for the phenotypes observed in these assays can be identified and characterized, it may be possible to determine which M. avium strains in the environment are potential human pathogens.

Entities:  

Mesh:

Year:  1999        PMID: 10456946      PMCID: PMC96824     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  Identification of virulence determinants in pathogenic mycobacteria.

Authors:  J E Clark-Curtiss
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

2.  The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.

Authors:  C Fréhel; C Offredo; C de Chastellier
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Analysis of plasmids in Mycobacterium avium-intracellulare isolates from persons with acquired immunodeficiency syndrome.

Authors:  J T Crawford; J H Bates
Journal:  Am Rev Respir Dis       Date:  1986-10

4.  DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients.

Authors:  S J Hampson; F Portaels; J Thompson; E P Green; M T Moss; J Hermon-Taylor; J J McFadden
Journal:  Lancet       Date:  1989-01-14       Impact factor: 79.321

5.  Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome.

Authors:  M A Yakrus; R C Good
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

6.  In vitro interaction of Mycobacterium avium with intestinal epithelial cells.

Authors:  M E Mapother; J G Songer
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Concentration of Mycobacterium avium by hospital hot water systems.

Authors:  G C du Moulin; K D Stottmeier; P A Pelletier; A Y Tsang; J Hedley-Whyte
Journal:  JAMA       Date:  1988-09-16       Impact factor: 56.272

8.  Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages.

Authors:  A J Crowle; A Y Tsang; A E Vatter; M H May
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

9.  Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome.

Authors:  P R Meylan; D D Richman; R S Kornbluth
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

10.  Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium.

Authors:  C Frehel; C de Chastellier; T Lang; N Rastogi
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

View more
  5 in total

1.  Novel rhamnosyltransferase involved in biosynthesis of serovar 4-specific glycopeptidolipid from Mycobacterium avium complex.

Authors:  Yuji Miyamoto; Tetsu Mukai; Takashi Naka; Nagatoshi Fujiwara; Yumi Maeda; Masanori Kai; Seiko Mizuno; Ikuya Yano; Masahiko Makino
Journal:  J Bacteriol       Date:  2010-09-03       Impact factor: 3.490

2.  Peptide aMptD-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in bulk milk samples.

Authors:  Janin Stratmann; Karen Dohmann; Julia Heinzmann; Gerald-F Gerlach
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

3.  Most human isolates of Mycobacterium avium Mav-A and Mav-B are strong producers of hemolysin, a putative virulence factor.

Authors:  Laura Rindi; Daniela Bonanni; Nicoletta Lari; Carlo Garzelli
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 4.  Mycobacterium avium in the postgenomic era.

Authors:  Christine Y Turenne; Richard Wallace; Marcel A Behr
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

5.  Genetic Variation/Evolution and Differential Host Responses Resulting from In-Patient Adaptation of Mycobacterium avium.

Authors:  T H Flo; M Steigedal; N Kannan; Y-P Lai; M Haug; M K Lilleness; S S Bakke; A Marstad; H Hov; T Naustdal; J E Afset; T R Ioerger
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.